Skip to main content Skip to main navigation menu Skip to site footer

Myasthenia gravis and arrhythmias in COVID-19: a case report

  • Dodik Tugasworo ,
  • Aditya Kurnianto ,
  • Retnaningsih Retnaningsih ,
  • Yovita Andhitara ,
  • Rahmi Ardhini ,
  • Daynuri Daynuri ,
  • Jethro Budiman ,


Background: Myasthenia Gravis (MG) is an autoimmune disorder, which autoantibodies against postsynaptic (muscle) nicotinic acetylcholine receptors (nAChR). MG patients have a higher prevalence of cardiac manifestations in the presence of thymoma. It is not known whether Coronavirus disease 2019 (COVID-19) can cause more severe illness in patients with chronic neuromuscular disorders such as MG, which can cause respiratory muscle weakness, or in those who are immunosuppressed. This case report will discuss patient with MG, thymoma, atrial fibrillation, and COVID-19.

Case presentation:  A 60-year old man came to the hospital with difficulty of swallowing. He had nasal voice and dropping of eyelids. These complaints were happened repeatedly, worsened at night and got better in the next morning. From the neurological examination, it was also obtained Wartenberg test (+), counting test (+), and prostigmine test (+). Atrial fibrillation was found with normal ventricular response and decreased systolic left ventricular function on the electrocardiogram and echocardiography. On the chest MSCT, a lobulated homogeneous solid mass was found in anterior mediastinum which supported the image of thymoma, and there was the imaging of typical viral pneumonia. The patient also had the positive result of COVID-19 PCR test.

Conclusion: MG patients have been shown with abnormal manifestations of heart rhythm. This may reflect as a complication of myocarditis or autonomic nervous system dysfunction. COVID-19 infection in MG can be challenging for many reasons. Current guidelines recommend continuing the current standard care treatment of MG during hospitalization.


  1. Drislane FW, Tarulli AW, Boegle A, Hovaguimian A, Mcllduff C, Caplan LR. Blueprints neurology. 5th ed. Philadelphia: Lippincott Williams and Wilkins (LWW); 2019.
  2. Cruz PMR, Al-Hajjar M, Huda S, Jacobson L, Woodhall M, Jayawant S, et al. Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis. JAMA Neurol. 2015;72(6):642–9.
  3. Gwathmey KG, Burns TM. Myasthenia gravis. Semin Neurol. 2015;35:327–39.
  4. Hehir MK, Silvestri NJ. Generalized Myasthenia Gravis: Classification, Clinical Presentation, Natural History, and Epidemiology. Neurol Clin. 2018;36(2):253–60.
  5. Cata JP, Lasala JD, Williams W, Mena GE. Myasthenia Gravis and Thymoma Surgery: A Clinical Update for the Cardiothoracic Anesthesiologist. J Cardiothorac Vasc Anesth. 2019;33(9):2537–45.
  6. Kamarudin S, Chairani L. Myasthenia gravis. Syifa’ Med. 2019;10(1):63–71.
  7. Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo HC, Marx A, et al. Randomized trial of thymectomy in myasthenia gravis. N Eng J Med. 2016;375(6):511–22.
  8. Zhang Z, Cui Y, Jia R, Xue L, Liang H. Myasthenia gravis in patients with thymoma affects survival rate following extended thymectomy. Oncol Lett. 2016;11(6):4177–82.
  9. Gilhus NE, Verschuuren JJ. Myasthenia gravis: Subgroup classification and therapeutic strategies. Lancet Neurol. 2015;14(10):1023–36.
  10. Shivamurthy P, Parker MW. Cardiac manifestations of myasthenia gravis: A systematic review. IJC Metab Endocr. 2014;5:3–6.
  11. Cǎlin C, Savu O, Dumitru D, Ghiorghiu I, Cǎlin A, Capraru C, et al. Cardiac involvement in myasthenia gravis--is there a specific pattern? Rom J Intern Med. 2009;47(2):179–89.
  12. Owe JF, Gilhus NE. Myasthenia gravis and the heart. ACNR. 2008;8(5):9–10.
  13. Susilo A, Rumende CM, Pitoyo CW, Santoso WD, Yulianti M, Herikurniawan H, et al. Coronavirus Disease 2019: Tinjauan Literatur Terkini. J Penyakit Dalam Indones. 2020;7(1):45–67.
  14. Pinzon RT, Wijaya VO, Buana RB, Al Jody A, Nunsio PN. Neurologic Characteristics in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis. Front Neurol. 2020;11:1–11.
  15. Anand P, Slama MCC, Kaku M, Ong C, Cervantes-Arslanian AM, Zhou L, et al. COVID-19 in patients with myasthenia gravis. Muscle Nerve. 2020;62(2):254–8.
  16. Singh S, Govindarajan R. COVID-19 and generalized Myasthenia Gravis exacerbation: A case report. Clin Neurol Neurosurg. 2020;196:1–2.
  17. Lefeuvre CM, Payet CA, Fayet OM, Maillard S, Truffault F, Bondet V, et al. Risk factors associated with myasthenia gravis in thymoma patients: The potential role of thymic germinal centers. J Autoimmun. 2020;106(September).
  18. Srinivasan J, Chaves C, Scott B, Small J. Netter’s neurology. 3rd ed. Amsterdam: Elsevier; 2019.
  19. Widjaja D, Puspitasari V. Case Report: Generalized Myasthenia Gravis. Medicinus. 2019;7(5):150–3.
  20. Elsheikh B, Arnold WD, Gharibshahi S, Reynolds J, Freimer M, Kissel JT. Correlation of single-breath count test and neck flexor muscle strength with spirometry in myasthenia gravis. Muscle Nerve. 2016;53(1):134–46.
  21. Nair AG, Patil-Chhablani P, Venkatramani D V, Gandhi RA. Ocular myasthenia gravis: A review. Indian J Opthalmol. 2014;62(10):985–91.
  22. Harahap IL. Myasthenia gravis. Maj Biomorfologi. 2015;28(1):6–11.
  23. Yamada Y, Weis CA, Thelen J, Sticht C, Schalke B, Ströbel P, et al. Thymoma Associated Myasthenia Gravis (TAMG): Differential Expression of Functional Pathways in Relation to MG Status in Different Thymoma Histotypes. Front Immunol. 2020;11(664):1–8.
  24. Limaye K, Vallurupalli S, Lee RW. Myasthenia of the Heart. Am J Med. 2016;129(6):e19–21.
  25. Hamed S, Mohamad K, Adam M. Cardiac autonomic function in patients with myasthenia gravis: analysis of the heart-rate variability in the time-domain. Neuroimmunol Neuroinflammation. 2015;2(1):21–5.
  26. Hickey RM, Cullen JD, Sachs GM. An Overview of Cardiac Management in Neuromuscular Disease. Open Cardiovasc Med J. 2016;10(1):82–8.
  27. Kato T, Hirose S, Kumagai S, Ozaki A, Matsumoto S, Inoko M. Electrocardiography as the First Step for the Further Examination of Cardiac Involvement in Myasthenia Gravis. Biomed Res Int. 2016;(1):1–4.
  28. Jacobs DH. Myasthenia Gravis Crisis and Atrial Fibrillation. Neurologist. 2020;25(1):1–3.
  29. Sanders DB, Wolfe GI, Benatar M, Evoli A, Gilhus NE, Illa I, et al. International consensus guidance for management of myasthenia gravis: Executive summary. Neurology. 2016;87(4):419–25.
  30. Kumar R. Myasthenia gravis and thymic neoplasms: A brief review. World J Clin Cases. 2015;3(12):980–3.
  31. Romi F. Thymoma in myasthenia gravis: From diagnosis to treatment. Autoimmune Dis. 2011;1(1):1–5.

How to Cite

Tugasworo, D., Kurnianto, A., Retnaningsih, R., Andhitara, Y., Ardhini, R., Daynuri, D., & Budiman, J. (2021). Myasthenia gravis and arrhythmias in COVID-19: a case report. Bali Medical Journal, 10(1), 314–319.




Search Panel